Target intelligence / Profile preview

Vesicle amine transport 1 like (VAT1L)

Target
VAT1L
Molecular classification
Oxidoreductase (specifically NADPH-dependent quinone oxidoreductase family), Integral membrane protein (associated with synaptic vesicle membranes), Protein-coding gene
01

Overview

VAT1L (Vesicle amine transport 1 like) is a protein encoded in humans by the *VAT1L* gene, related to VAT1 and highly conserved across vertebrates. VAT1L is predicted and partly validated to have oxidoreductase activity within the NADPH-dependent quinone oxidoreductase family, and functions as an integral membrane protein in cholinergic synaptic vesicles, possibly regulating vesicle transport. It may also modulate mitochondrial fusion and participate in phospholipid transfer between the endoplasmic reticulum and mitochondria. Limited experimental evidence suggests roles in cell migration and cancer cell motility, indicating VAT1L as a potential but unvalidated anticancer drug target; a naturally occurring product (neocarzilin A) inhibits VAT1-regulated cell motility. VAT1L is a paralog of VAT1 and is expressed in multiple tissues, particularly in nervous system structures. There is no direct evidence of VAT1L serving as a receptor, ion channel, transporter, or being involved in signal transduction, and its molecular mechanism and authentic substrates remain only partly characterized.

Other names
Synaptic vesicle membrane protein VAT-1 homolog-likeVAT1LKIAA1576Vesicle amine transport protein 1 homolog (T. californica)-likeVesicle amine transport protein 1 homolog-like (T. californica)Vesicle amine transport 1-like
02

Mechanism of action

Inhibiting VAT-1-related pathways reduces cancer cell motility (in vitro), potentially by modulating redox and vesicular processes in cancer cells

03

Biological functions

Oxidoreductase activity (quinone reduction)Zinc ion bindingVesicular transport in cholinergic synaptic vesiclesMitochondrial fusion modulationPhospholipid transport (putative)Regulation of cell migration, cancer cell motility
04

Disease associations

Cancer (implicated in cell motility and potential anticancer drug targeting)No direct evidence for major disease roles such as neurodegenerative diseases, cardiovascular diseases, or inflammation
05

Safety considerations

None documented. Safety or toxicity profiles are unknown due to lack of drug development against VAT1L
06

Interacting drugs

Neocarzilin A (NCA): A natural polyenone described as a potent inhibitor of cancer cell motility acting through VAT-1-controlled pathways. No approved drugs directly target VAT1L
07

Biomarkers

None reported. VAT1L is not validated as a clinical biomarker for patient selection or efficacy monitoring in the literature

Beyond the preview

Go deeper on Vesicle amine transport 1 like (VAT1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vesicle amine transport 1 like (VAT1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call